Glass particles should be one of the last things you’d ever think about reaching the deep crevices of your nasal passageway, but the most recent recall asks you to do just that.

Apotex Corporation is recalling lots of its Fluticasone Propionate products due to the potential for glass particles to compromise the safety of the user.

In a Safety Alert issued by the U.S. Food and Drug Administration, the particles could block the functionality of the spray pump as well as expose the patient to irritation should the particles be small enough to escape through the pump.

The nasal spray with lot #NJ4501 is the contender in recent recall news. It has an expiration date of July 2020 and can be found under brand names Cutivate, Flonase Allergy Relief and 24 Hour Allergy Relief.

The FDA recommends that patients, wholesalers, retailers, hospitals or institutions should immediately stop using the product and quarantine remaining units.

Fluticasone Propionate is a common treatment for seasonal allergies, and to manage sinus pain and pressure. It is recommended for patients 4 to 77 years old.

Though no reports of adverse events have been received by Apotex Corp., it is important for patients to contact their physician to receive a new prescription.

The issue was brought to light by a consumer complaint which triggered the issue of a voluntary recall. Anyone concerned about their Fluticasone Propionate nasal spray should contact their physician.